Jesse Treu - Profile and Investment Details

Investor Profile

Jesse Treu is a Venture Capital, Founder, Investor based in New York City, New York, United States with a diverse investment portfolio that includes companies such as Epic Sciences, Colorescience, Esperion Therapeutics, Astute Medical, Exalys Therapeutics, WindMIL Therapeutics, BiPar Sciences, Zyga Technology, Atara Biotherapeutics, VentiRx Pharmaceuticals, Celtaxsys, Truvian Sciences, Gene Sciences, Inc., Kona Medical, Veracyte, CoLucid PharmaceuticalsDicerna Pharmaceuticals, NovaDigm Therapeutics, Benvenue Medical, Miramar Labs, Ocunexus Therapeutics, Cotera, Regado Biosciences, Obalon Therapeutics, Sequent Medical, Marinus Pharmaceuticals, ReVision Optics, Neothetics, Aspen Neuroscience, Sera Prognostics, Afferent Pharmaceuticals, Sebacia, Omniome, Xagenic, Fractyl Laboratories, Axial Biotherapeutics, NPS Pharmaceuticals, Seraphina Therapeutics, ChromaCode, Achaogen, Milestone Pharmaceuticals, Evofem Biosciences, Applied Proteomics, Apnex Medical, Bionano Genomics, Smart Medical Systems, Twelve, Nobias Therapeutics, RightCare Solutions, Antios Therapeutics, Adynxx, Tandem Diabetes Care, Glaukos, Otonomy, Singular Genomics, aTyr Pharma, ROX Medical, Iterum Therapeutics, Syndax Pharmaceuticals, . Over time, Jesse Treu has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Jesse Treu is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Industrial Energy Efficiency, Health Care, Digital Services, Power Plant, Customer Service, Wellness, Women Founded, Energy Infrastructure, Energy, Life Science, Technology, Finance, Manufacturing, Biotechnology, Energy Tech, System Integration, Consulting, Sustainable Energy, Utilities, Health Diagnostics, Renewable Energy, Medical, B2B, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with Jesse Treu, as their portfolio suggests a familiarity and interest in this area.

Understanding Jesse Treu’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.